Your browser doesn't support javascript.
loading
Skin dendritic cells in melanoma are key for successful checkpoint blockade therapy.
Prokopi, Anastasia; Tripp, Christoph H; Tummers, Bart; Hornsteiner, Florian; Spoeck, Sarah; Crawford, Jeremy Chase; Clements, Derek R; Efremova, Mirjana; Hutter, Katharina; Bellmann, Lydia; Cappellano, Giuseppe; Cadilha, Bruno L; Kobold, Sebastian; Boon, Louis; Ortner, Daniela; Trajanoski, Zlatko; Chen, Suzie; de Gruijl, Tanja D; Idoyaga, Juliana; Green, Douglas R; Stoitzner, Patrizia.
Afiliação
  • Prokopi A; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Tripp CH; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Tummers B; Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Hornsteiner F; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Spoeck S; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Crawford JC; Department of Immunology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
  • Clements DR; Department of Micobiology & Immunology, Stanford University School of Medicine, Stanford, California, USA.
  • Efremova M; Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.
  • Hutter K; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Bellmann L; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Cappellano G; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Cadilha BL; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
  • Kobold S; Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Boon L; Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
  • Ortner D; Member of the German Center for Lung Research (DZL), Munich, Germany.
  • Trajanoski Z; German Center for Translational Cancer Research (DKTK), partner site Munich, Munich, Germany.
  • Chen S; Bioceros BV, Utrecht, The Netherlands.
  • de Gruijl TD; Department of Dermatology, Venereology & Allergology, Medical University of Innsbruck, Innsbruck, Austria.
  • Idoyaga J; Institute of Bioinformatics, Medical University of Innsbruck, Innsbruck, Austria.
  • Green DR; Ernest Mario School of Pharmacy and Rutgers Cancer Institute, Rutgers University, New Brunswick, New Jersey, USA.
  • Stoitzner P; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands.
J Immunother Cancer ; 9(1)2021 01.
Article em En | MEDLINE | ID: mdl-33408092
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Melanoma Experimental / Poli I-C / Receptor de Morte Celular Programada 1 / Receptor Celular 2 do Vírus da Hepatite A / Inibidores de Checkpoint Imunológico / Anticorpos Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pele / Melanoma Experimental / Poli I-C / Receptor de Morte Celular Programada 1 / Receptor Celular 2 do Vírus da Hepatite A / Inibidores de Checkpoint Imunológico / Anticorpos Limite: Animals / Humans Idioma: En Revista: J Immunother Cancer Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Áustria